To demonstrate the antiviral effect of poly-gamma-glutamic acid in Human papilloma virus positive patients

Trial Profile

To demonstrate the antiviral effect of poly-gamma-glutamic acid in Human papilloma virus positive patients

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Jun 2017

At a glance

  • Drugs Polyglutamic acid (Primary)
  • Indications Human papillomavirus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Jun 2017 New trial record
    • 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top